High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6 / 11 / 16 / 18 L1 virus-like particle vaccine through 5 years of follow-up. - Villa, L L; Costa, R L; Petta, C A (Br J Cancer, 2006)
et al